Literature DB >> 11375436

The role of apolipoprotein A-IV in the regulation of food intake.

P Tso1, M Liu, T J Kalogeris, A B Thomson.   

Abstract

Apolipoprotein A-IV (apo A-IV) is a glycoprotein synthesized by the human intestine. In rodents, both the small intestine and liver secrete apo A-IV, but the small intestine is the major organ responsible for the circulating apo A-IV. Intestinal apo A-IV synthesis is markedly stimulated by fat absorption and appears not to be mediated by the uptake or reesterification of fatty acids to form triglycerides. Rather, the formation of chylomicrons acts as a signal for the induction of intestinal apo A-IV synthesis. Intestinal apo A-IV synthesis is also enhanced by a factor from the ileum, probably peptide tyrosine-tyrosine. The inhibition of food intake by apo A-IV is mediated centrally. The stimulation of intestinal synthesis and the secretion of apo A-IV by lipid absorption are rapid; thus, apo A-IV likely plays a role in the short-term regulation of food intake. Other evidence suggests that apo A-IV may also be involved in the long-term regulation of food intake and body weight. Chronic ingestion of a high-fat diet blunts the intestinal apo A-IV response to lipid feeding and may explain why the chronic ingestion of a high-fat diet predisposes both animals and humans to obesity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375436     DOI: 10.1146/annurev.nutr.21.1.231

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  17 in total

1.  Apolipoprotein A-IV is involved in detection of lipid in the rat intestine.

Authors:  K L Whited; D Lu; P Tso; K C Kent Lloyd; H E Raybould
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

Review 2.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 3.  Using the cerebrospinal fluid to understand ingestive behavior.

Authors:  Stephen C Woods; Aaron A May; Min Liu; Patrick Tso; Denovan P Begg
Journal:  Physiol Behav       Date:  2016-12-05

4.  Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function.

Authors:  Alison B Kohan; Fei Wang; Xiaoming Li; Suzanne Bradshaw; Qing Yang; Jody L Caldwell; Tera M Bullock; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-29       Impact factor: 4.052

Review 5.  CNS-targeting pharmacological interventions for the metabolic syndrome.

Authors:  Kerstin Stemmer; Timo D Müller; Richard D DiMarchi; Paul T Pfluger; Matthias H Tschöp
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

Review 6.  Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism.

Authors:  Chi-Liang Eric Yen; David W Nelson; Mei-I Yen
Journal:  J Lipid Res       Date:  2014-09-17       Impact factor: 5.922

Review 7.  Obesity surgery and gut-brain communication.

Authors:  Hans-Rudolf Berthoud; Andrew C Shin; Huiyuan Zheng
Journal:  Physiol Behav       Date:  2011-02-24

8.  Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

Authors:  E Pardina; M D López-Tejero; R Llamas; R Catalán; R Galard; H Allende; V Vargas; A Lecube; J M Fort; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

9.  Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oil.

Authors:  Roberto Martínez-Beamonte; María A Navarro; Sergio Acin; Natalia Guillén; Cristina Barranquero; Carmen Arnal; Joaquín Surra; Jesus Osada
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

10.  Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride?

Authors:  Alison B Kohan; Fei Wang; Xiaoming Li; Abbey E Vandersall; Sarah Huesman; Min Xu; Qing Yang; Danwen Lou; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-18       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.